405 filings
Page 2 of 21
424B3
xdfdu
10 May 19
Prospectus supplement
3:26pm
424B3
6kp6jwq
10 May 19
Prospectus supplement
3:18pm
6-K
yn2li
10 May 19
Primary Document
1:07pm
6-K
iosk9wvl1qmg1yr
8 May 19
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing
12:00am
424B3
7sun041k4q2j
26 Apr 19
Prospectus supplement
12:13pm
424B3
2r5ou uyvu5
26 Apr 19
Prospectus supplement
12:10pm
6-K
4ucifth5k4ktsmxe
26 Apr 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
12:00am
424B3
pmikp08f
17 Apr 19
Prospectus supplement
10:49am
424B3
3nnex6i3 xkh
17 Apr 19
Prospectus supplement
10:46am
6-K
in13o2ne
15 Apr 19
Primary Document
4:25pm
424B3
aqhij
29 Mar 19
Prospectus supplement
8:57am
424B3
ehl2agt9o lnf
29 Mar 19
Prospectus supplement
8:55am
6-K
wev wyaco0zo
29 Mar 19
Primary Document
8:53am
424B3
f84dhq6ar jn
20 Mar 19
Prospectus supplement
7:50am
424B3
empk 2qinf
20 Mar 19
Prospectus supplement
7:46am
6-K
mu2q2sr5l 45zk9im8
20 Mar 19
To Begin Trading on the OTC Markets System
12:00am
424B3
tibtzv7rxsm
4 Mar 19
Prospectus supplement
8:34am
424B3
0f9pnfqf
4 Mar 19
Prospectus supplement
8:04am
6-K
wz2rnhqqy
4 Mar 19
Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
7:40am
6-K
3xn5pf1p6
4 Mar 19
Primary Document
7:13am